Min Li
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Cystic Fibrosis Research Advances
- Pulmonary Hypertension Research and Treatments
- Neonatal Respiratory Health Research
- Ferroptosis and cancer prognosis
- Cancer Research top 5%
Papers in
-
- Pulmonary Hypertension Research and Treatments 19
- Cystic Fibrosis Research Advances 19
- Neonatal Respiratory Health Research 13
- Ferroptosis and cancer prognosis 9
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 6
-
- Advanced biosensing and bioanalysis techniques 12
- Epigenetics and DNA Methylation 5
- Co-authors
- Tzyh‐Chang Hwang (11 shared papers)Yufei Xiang (1 shared paper)Bingwen Liu (1 shared paper)Zhiguang Zhou (1 shared paper)Xuan Guan (1 shared paper)William B. Guggino (3 shared papers)Kurt R. Stenmark (15 shared papers)Shusheng Wang (2 shared papers)
- Journals
- The Journal of General Physiology (8 papers)Frontiers in Oncology (5 papers)Journal of Biological Chemistry (5 papers)Frontiers in Immunology (4 papers)Cell Death and Disease (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Min Li
131 papers receiving 4.5k citations
Min Li's Hit Papers
Peers
Comparison fields: 5 of 131
- Pulmonary and Respiratory Medicine 2.3k
- Cancer Research 453
- Molecular Biology 1.8k
- Oncology 628
- Infectious Diseases 396
Countries citing papers authored by Min Li
This map shows the geographic impact of Min Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Li more than expected).
Fields of papers citing papers by Min Li
This network shows the impact of papers produced by Min Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Li. The network helps show where Min Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? Hit paper breakdown → | 2020 | 560 |
| 2 | Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer Hit paper breakdown → | 2022 | 356 |
| 3 | 1998 | 230 | |
| 4 | 2002 | 197 | |
| 5 | 2011 | 184 | |
| 6 | 2010 | 181 | |
| 7 | 2007 | 158 | |
| 8 | 2012 | 140 | |
| 9 | 2000 | 139 | |
| 10 | 2019 | 90 | |
| 11 | 2021 | 90 | |
| 12 | 2019 | 85 | |
| 13 | 2017 | 84 | |
| 14 | 2010 | 75 | |
| 15 | 2010 | 71 | |
| 16 | 2006 | 66 | |
| 17 | 2009 | 58 | |
| 18 | 2002 | 57 | |
| 19 | 2011 | 55 | |
| 20 | 2013 | 54 |
About Min Li
Min Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Oncology and Cancer Research, having authored 145 papers that have together received 4.6k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (19 papers), Cystic Fibrosis Research Advances (19 papers), Neonatal Respiratory Health Research (13 papers), Advanced biosensing and bioanalysis techniques (12 papers), Ferroptosis and cancer prognosis (9 papers), Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.3k citations), Cancer Research (453 citations), Molecular Biology (1.8k citations), Oncology (628 citations) and Infectious Diseases (396 citations). Min Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Tzyh‐Chang Hwang, Yufei Xiang, Bingwen Liu, Zhiguang Zhou, Xuan Guan, William B. Guggino, Kurt R. Stenmark, Shusheng Wang, Ronald W. Raab and Peter J. Schatz. Their work appears in journals such as The Journal of General Physiology, Frontiers in Oncology, Journal of Biological Chemistry, Frontiers in Immunology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.